Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
|
KIDS MEDICAL SYSTEMS LIMITED Our Company was incorporated as 'Kids Medical Systems Private Limited' under the provision of the Companies Act, 1956 vide certificate of incorporation dated Way 22, 2013 issued by the Assistant Registrar of Companies, Gujarat, Dadra and Nagar Haveli, Consequent upon the conversion of our Company to public limited company, the name of our Company was changed to 'Kids Medical Systems Limited' and fresh certificate of incorporation dated September 7, 2017 was issuad by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of our Company is U85110GJ2013PLC075191. Registered Office-: F-806 Titanium City Center, Nr.
Sachin Towers, 100 Feet Ring Road, Anand Nagar Road, Satellite, Ahmedabad-380015. Compan.y Secretary and Compliance Officer: Ms. Falguni Dhrumil Shah; E-Mail: pallavi.dam@thekidsclinic.in PROMOTERS OF THE COMPANY: MR. ANIRVAN AMITAVA DAM & MRS. PALLAVI ANIRVAN DAM BASIS OF ALLOTMENT PUBLIC ISSUE OF 20,00,000 EQUITY SHARES OF FACE VALUE OF RS 10/- EACH OF KIDS MEDICAL SYSTEMS LIMITED ('KMSL' OR THE 'COMPANY' OR THE 'ISSUER') FOR CASH AT A PRICE OF RS 30 PER EQUITY SHARE INCLUDING A SHARE PREMIUM OF RS 20 PER EQUITY SHARE (THE 'ISSUE PRICE') AGGREGATING TO RS 600.00 LACS ('THE ISSUE'), OF WHICH 1,04,000 EQUITY SHARES OF FACE VALUE OF RS 10 EACH WILL FOR CASH AT A PRICE OF RS 30 PER EQUITY SHARE INCLUDING A SHARE PREMIUM OF RS 20 PER EQUITY SHARE AGGREGATING TO RS 31.20 LACS WILL BE RESERVED FOR SUBSCRIPTION BY MARKET MAKER TO THE ISSUE (THE 'MARKET MAKER RESERVATION PORTION'). THE ISSUE LESS THE MARKET MAKER RESERVATION PORTION i.e. NET ISSUE OF 18,96,000 EQUITY SHARES OF FACE VALUE OF RS 10 EACH AT APRICE OF RS 30 PER EQUITY SHARE AGGREGATING TO RS 568.80 LACS IS HEREIN AFTER REFERRED TO AS THE 'NET ISSUE', THE ISSUE AND THE NET ISSUE WILL CONSTITUTE 28.20% AND 26.74%, RESPECTIVELY OF THE POST ISSUE PAID UP EQUITY SHARE CAPITAL OF OUR COMPANY. In terms of Prospectus dated December 01, 2017and as per Regulation 43(4) of SEBl (ICDR) Regulations, 2009 wherein (a) minimum of 50% of the Net Offer to Public shall be initially made available to Retail Individual Investors as the case may be (b) The balance net offer of shares to the public shall be made available for allotment to i) individual applicants other than retail investors: and ii) other investors including corporate bodies or Institutions, irrespective of no. of shares applied for. Explanation: for the purpose of Regulation 43(4) of SEBI (ICDR) Regulations, 2009. if the retail individual investor is entitled to more than fifty percent, on proportionate basis, the retail individual investors shall be allocated that higher percentage. THE FACE VALUE OF THE EQUITY SHARES IS RS 10 EACH AND THE ISSUE PRICE IS RS 30/- EACH. THE ISSUE PRICE IS 3 TIMES OF THE FACE VALUE ISSUE OPENED ON (MONDAY) DECEMBER 11, 2017, ISSUE CLOSED ON (THURSDAY) DECEMBER 14, 2017 The Equity Shares offered through the Prospectus are proposed to be listed on the BSE SME Platform. Our Company has received an approval letter datad November 27, 2017 from BSE for using its name in this offer document for listing our shares on the SME Platform of BSE. For the purpose of this Issue, the designated Stock Exchange will be the BSE Limited ('BSE'). SUBSCRIPTION DETAILS Details of the application The Issue has received 3965 (before rejections) applications for 1,77,08,000 Equity Shares (Including Market Maker Application of 1,04,000 Equity Shares) resulting 8.85 times subscription. The details of the applications received in the Issue (before technical rejections) are as follows; Detail of the valid Applications Received (Before Technical Rejection of application);
Total 28 applications received in Retail Individual Investors Category for 1,12,000 Shares were rejected on technical grounds and 2 applications received in Retail Individual investors Category for 8,000 shares were rejected on Multiple Bid. ALLOCATION: The Basis of Allotment was finalized in consultation with the Designated Stock Exchange - BSE Limited ('SME Platform of BSE') on December 19, 2017. A. Allocation to Market Maker: The Basis of Allotment to the Market Maker, at the issue price of Rs.30 /- per Equity Share, was finalised in consultation with BSE. The category was subscribed by 1.00 times. The total number of shares allotted in this catagory is 1,04,000 Equity shares in full out of reserved portion of 1,04,000 Equity Shares. B. Allocation to Retail Individual Investors (After Technical Rejections): The Basis of Allotment to the Ratail Individual Investors, at the issue price of Rs.30/- per Equity Share, was finalized in consultation with BSE The category was subscribed by 16.42 times. Total number of shares allotted in this category is 16,88,000:
C. Allocation to Non Retail Investors (After Technical Rejections); The Basis of Allotment to the Non Retail Investors, at the issue price of Rs.30/- per Equity Share, was finalized in consultation with BSE The category was subscribed by 2.03 times Total number of shares allotted in this category is 2,08,000:
The Board of Directors of the Company at its meeting held on Decernber 19, 2017 has taken on record the Basis at Allotment of Equity Shares approved by the Designated Stock Exchange viz. BSE and has authorized the corporate action for the allotment of the Equity Shares in dematerialised form to various successful applicants. The CAN-cum-Refund Orders and allotment advice and/or notices are being dispatched to the address of the Applicants as registered with the depositories / as filled in the application form on or before December 21, 2017. Further, the instructions to self Certified Syndicate Banks being processed on or prior to December 21, 2017. In case the same is not received within 10 days, investors may contact at the address given below. The Equity Shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is taking steps to get the Equity Shares admitted for trading on the SME Platform of BSE Limited within six working days from the date of the closure of the Issue. The trading is proposed to be commenced on or before December 22, 2017 subject to receipt of listing and trading approvals from the BSL Limited ('SME Platform of BSE'). INVESTORS PLEASE NOTE The details of the allotment made would also be hosted on the website of the Registrar to the issue, Purva Sharegistry (India) Private Limited at www.purvashare.com . All future correspondence in this regard may kindly be addressed to the Registrar to the issue quoting full name of the First/Sole applicants, serial number of the Application Form, number of shares applied for and Bank Branch where the application had been lodged and payment details at the address of the Registrar given below: PURVA SHAREGISTRY (INDIA) PRIVATE LIMITED
|
The IPO allocation is based on the subscription level and the investor category.
Refer to IPO allotment rules and methods for more details.
See the basis of allotment document above to know how the shares are allocated in Kids Medical Systems IPO .
The Kids Medical Systems IPO basis of allotment (published above) tells you how shares are allocated to you in Kids Medical Systems IPO and category wise demand of IPO share.
Visit the Kids Medical Systems IPO allotment status page to check the number of shares allocated to your application.
In Kids Medical Systems IPO allotment process, the registrar separates valid and invalid applications. The invalid applications with technical errors are rejected and only valid applications at or above the cut-off price are considered for allotment.
For more information, please refer to IPO Allotment Process and Basis of Allotment.
Check the Kids Medical Systems IPO basis of allotment document to know how the shares are allocated in Kids Medical Systems IPO.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
